Company Overview and News

21
John And Jane: June Dividend Income Tracker - Taxable Account

2018-07-16 seekingalpha
June marks the eighth month I have officially tracked the taxable account's dividend income. The total amount of dividend income received was $676.96.
SOJA ETP.PRC GIS XOM IDCC EPR.PRG O.PRF SKT LTC OPRF BPL SEP COP MIC CINF AAPL CAH EMR BBT SO TLP WLK O MSB OZRK CMI ETP SPG.PRJ HP ORI SPG WPC ADM

7
WLK vs. POL: Which Stock Is the Better Value Option?

2018-07-16 zacks
Investors looking for stocks in the Chemical - Plastic sector might want to consider either Westlake Chemical (WLK - Free Report) or PolyOne (POL - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
GTT WLK SFIX POL

3
PPG Industries Launches Next-Generation Electrocoat in China

2018-07-09 zacks
PPG Industries, Inc. (PPG - Free Report) has unveiled its next-generation electrocoat (e-coat) primer — PPG Enviro-Prime 8000 — for automotive original equipment manufacturers (OEMs) serving China’s market. The company expects to supply the product across China’s domestic OEM locations by the end of this year. The new cathodic dip primer boosts the company’s capabilities to address the unique demands of domestic OEMs in China.
X PPG WLK CVRR MEOH

5
Methanex (MEOH) Up 12% in 3 Months: What's Driving the Stock?

2018-07-09 zacks
Shares of Methanex Corporation (MEOH - Free Report) have popped around 12% over the past three months, significantly outperforming the industry’s gain of roughly 1.3%. Methanex, a Zacks Rank #1 (Strong Buy) stock, has a market cap of roughly $6 billion and average volume of shares traded in the last three months was around 586K. The company has an expected long-term earnings per share growth rate of 15%, higher than the industry average of 10.
RYAM VSM.WI WLK RYAM.PRA VSM MEOH

4
Buy These 5 Low Leverage Stocks on Chances of Rate Hike

2018-07-07 investorplace
In corporate finance, leverage, otherwise termed as debt financing, is the use of exogenous funds by corporations to run their operations smoothly and expand the same. While there is option for equity financing, if a company wants to avoid debt, historically debt financing has been preferred over equity.
MGP WLK HFC AMED BRO

4
Buy These 5 Low Leverage Stocks on Chances of Rate Hike

2018-07-06 zacks
In corporate finance, leverage, otherwise termed as debt financing, is the use of exogenous funds by corporations to run their operations smoothly and expand the same. While there is option for equity financing, if a company wants to avoid debt, historically debt financing has been preferred over equity.
WLK MGP HFC AMED BRO

3
Platform Specialty (PAH) Up 22% in 3 Months: Here's Why

2018-07-06 zacks
Shares of Platform Specialty Products Corporation (PAH - Free Report) have rallied 22.4% in the past three months compared with the industry’s rise of roughly 1.7%.
X PAH WLK CC MRC

2
Newmont (NEM) Achieves Commercial Production at Twin Creeks

2018-07-05 zacks
Newmont Mining Corporation (NEM - Free Report) said that its Twin Creeks Underground expansion project has achieved commercial production and the project was completed on schedule for $42 million (below initial guidance of $45-$55 million). The project enables the company to add higher-grade, lower-cost gold production at its Twin Creeks operation in Nevada. The mine will add 30,000-40,000 ounces of gold per annum at all-in sustaining costs of $650-$750 per ounce for the initial five years of production.
ABX WLK NEM CC ABX

2
U.S. Steel (X) Up 54% in a Year: What's Behind the Rally?

2018-07-05 zacks
Shares of United States Steel Corporation (X - Free Report) have shot up around 54% over a year, significantly outperforming the industry’s growth of roughly 15%. U.S. Steel, a Zacks Rank #1 (Strong Buy) stock, has a market cap of roughly $6 billion and average volume of shares traded in the last three months was around 9,892.2K. The company has an expected long-term earnings per share growth rate of 8%.
X DB VSM.WI WLK VSM CC DLPH

4
5 Reasons to Add Ashland (ASH) Stock to Your Portfolio

2018-07-04 zacks
Ashland Global Holdings Inc. (ASH - Free Report) has been performing well of late. The company has seen its shares pop roughly 11% over the past three months. Forecast-topping second-quarter fiscal 2018 results, upbeat outlook, dividend hike and strategic initiatives have contributed to the gain in Ashland’s shares. If you haven’t taken advantage of the share price appreciation yet, the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead.
BHI BLT VSM.WI BHP WLK BHPBF ASH BBL BHP VSM BHPLF CC

3
Ingevity (NGVT) Stock Up 43% in a Year: What's Driving it?

2018-07-03 zacks
Shares of Ingevity Corporation (NGVT - Free Report) have rallied 43.3% in the past year against the industry’s decline of roughly 1.2%.
ABX WLK FTI.WI FMC NGVT CC NGVT.WI ABX

3
Here's Why You Should Add U.S. Steel (X) to Your Portfolio

2018-07-03 zacks
United States Steel Corporation’s (X - Free Report) stock looks promising at the moment. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it is poised to carry the momentum ahead. Let’s take a look into the factors that make this steel giant a compelling choice for investors right now. What’s Working in Favor of X? Solid Rank & VGM Score: U.
X ABX WLK FTI.WI FMC CC ABX

31
Here's Why You Should Add FMC Corp (FMC) to Your Portfolio

2018-07-02 zacks
FMC Corporation (FMC - Free Report) has been performing well of late. The chemical company has seen its shares pop around 17% over the past three months, outperforming the industry’s 3.6% rise. The price performance has been backed by strong first-quarter results and the company’s upward guidance revision for the full year. With strong fundamentals and solid long-term growth prospects, this stock can be considered a solid bet now.
VSM.WI WLK FTI.WI FMC VSM CC

26
Steel Dynamics (STLD) Wraps Up Heartland Buyout for $400M

2018-07-02 zacks
Steel Dynamics, Inc. (STLD - Free Report) has completed the previously announced acquisition of Heartland Steel Processing, LLC, formerly known as Companhia Siderurgica Nacional, LLC (Heartland), from CSN Steel, S.L.U., for $400 million in cash (including $60 million of normalized working capital), subject to customary transaction purchase price adjustments. The deal was funded with available cash with an expectation of near-term cash flow and earnings per share accretion.
STLD WLK FTI.WI FMC CC

26
5 Reasons to Add LyondellBasell (LYB) to Your Portfolio Now

2018-07-02 zacks
LyondellBasell Industries N.V.'s (LYB - Free Report) stock looks promising at the moment. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead. Let’s delve deeper into the factors that make this chemical giant an intriguing choice for investors right now. What Makes LYB an Attractive Pick? Solid Rank & VGM Score: LyondellBasell currently has a Zacks Rank #2 (Buy) and a VGM Score of A.
WLK LYB FTI.WI FMC CC

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to WLK / Westlake Chemical Corp. on message board site Silicon Investor.

PWLK security for our cars and trucks, wheels and tires even
CUSIP: 960413102